File Your Claim Request Today

Contact Preference

Is Truvada Responsible for Your Kidney or Bone Problems?

Tenofovir Disoproxil Fumarate or TDF drugs are antiretroviral medications used to prevent and treat HIV/AIDS. They are used along with other medications to help treat HIV infections. They are also used as preventative measures for individuals at high risk of developing HIV.

AImage of an animated view into the abdomen, showing the kidneys

Gilead Sciences manufactures five TDF drugs: Truvada, Viread, Atripla, Complera, and Stribild.

All five drugs have been linked to adverse effects, including kidney failure, bone fractures, or death, according to the U.S. Food and Drug Administration.

Truvada is one of the most common preventive medicines against HIV, used for pre-exposure prophylaxis (PrEP) in adults and adolescents at risk of HIV who are currently HIV negative. It must be prescribed and can only be used by those weighing at least 77 pounds.

For almost 15 years, Gilead Sciences, Inc., has aggressively marketed Truvada even though it has severe side effects which cause kidney and bone damage.

These side effects include:

  • Too much lactic acid in your blood
  • Acute kidney injury
  • Chronic kidney disease
  • Kidney failure
  • Softened bones, leading to fractures
  • Osteoporosis
  • Osteopenia
  • Other kidney and bone-related issues

TDF drugs have also been shown to reduce bone density by 2 to 6%.

The HIV/AIDS epidemic ravaged the United States in the 80s and 90s. Even today, gay and bisexual men, transgender women, and black and Latino communities remain disproportionately impacted by HIV/AIDs.

These communities deserve better methods of HIV prevention and treatment. Gilead Sciences downplayed the risks of Truvada while marketing the drug, leading to devastating bone and kidney damage for unsuspecting Truvada users.

Hold Gilead Responsible

At present, Gilead Sciences controls the U.S market for HIV treatment drugs. More than 80% of patients take one of Gilead’s products daily. With $80 billion in sales, Gilead has a lot of incentive to maintain this stranglehold on the market. The company has faced multiple allegations of monopoly and of keeping safer alternatives to Truvada off the market.

Image of a man in a hospital gown sitting on a hospital bed, looking at the camera

Recently, its shareholders sued Gilead for its records in an effort to look into monopolization and control over patents pertaining to HIV medications. Lawsuits allege that Gilead Sciences clamped down on generic competition through agreements with rivals. They also allege that it unfairly made profits off government patents and withheld safety information.

It is shocking that Gilead Sciences has placed people over profits in this way. It has pushed a drug that is known to have dangerous side effects, and may have purposely postponed releasing a safer alternative.

Profiting off patients’ health is inexcusable. Gilead must be held responsible for putting consumers at risk under the guise of preventing HIV.

We Can Help

Many people have suffered because of Gilead’s negligence. The company should be held responsible for its conduct and compensate those who have suffered because of Truvada or any of its other drugs.

Our nationwide team of lawyers is skilled at handling drug-related injury cases. If you or a loved one has taken Truvada or any of the five other TDF drugs and were diagnosed with kidney or bone problems, reach out to us today for a free expert consultation. All consultations are 100% confidential, and you won’t pay a penny unless and until you receive a settlement.

Join the thousands of individuals holding Gilead responsible to keep future users safe.